Vaccine mooted for bacterial vaginosis

Australian researchers say they are a step closer to developing a vaccine to prevent bacterial vaginosis, the most common vaginal infection worldwide.

Caused by the bacteria Gardnerella vaginalis, a team from St Vincent’s Institute Medical Research in Melbourne have shown how it targets cells and causes infection in women.

One of the bacteria’s tools for establishing infection is a protein toxin, vaginolysin.